X
KEY PRODUCTS KEY SERVICES
https://www.api.polpharma.com/news/first-cadifa-certification-from-anvisa-for-etodolac/
https://www.europeanpharmaceuticalreview.com/article/214953/forward-thinking-cdmo-tackles-the-dynamic-challenge-of-n-nitrosamines-control-with-high-performance-analytical-instrumentation/
https://www.api.polpharma.com/wp-content/uploads/2024/05/Forward-thinking-CDMO-tackles-the-Dynamic-Challenge-of-N-Nitrosamines-Control-with-High-Performance-Analytical-Instrumentation.pdf
https://www.dksh.com/global-en/home/media/news?id=en-2d99484f-56ea-4b41-985e-b4b25fb9d537:1
https://www.api.polpharma.com/news/kilolab-laboratory-another-polpharma-api-business-unit-strategy-milestone-achieved/
https://polpharma.pl/en/pre-filled-syringes-filling-and-packaging-line-for-sale/
https://polpharma.pl/en/aseptic-ophthalmics-filling-line-including-the-solution-preparation-units-for-sale/
https://ryvu.com/2023/07/06/ryvu-therapeutics-enters-into-two-agreements-with-zaklady-farmaceutyczne-polpharma-s-a-in-the-area-of-rvu120-active-substance-api-production-for-phase-ii-clinical-trials/#:~:text=Krakow%2C%20Poland%20%E2%80%93%20July%206%2C,in%20the%20area%20of%20RVU12006%2C,in%20the%20area%20of%20RVU120
https://polpharma.pl/en/polpharma-received-golden-csr-leaf-for-the-9th-time/
Market Place
Share 
